NRx Pharmaceuticals (NRXP) Balance Sheet: Assets & Liabilities

NRx Pharmaceuticals (NRXP) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), NRx Pharmaceuticals reported total assets of $12.96M and total liabilities of $28.89M. Shareholders' equity was negative at −$15.94M, meaning liabilities exceed assets. Total debt stood at $631.00K against $7.80M in cash and short-term investments, a net cash position of $7.17M.

NRx Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for NRx Pharmaceuticals, Inc. (NRXP) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Mar 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	7.80	1.44	4.60	4.60	20.05	27.61	27.61	1.86	0.00	0.01	0.45
Cash & Short-Term Investments	7.80	1.44	4.60	4.60	20.05	27.61	27.61	1.86	0.00	0.01	0.45
Accounts Receivable	0.16	0.00	0.01	0.01	0.01	0.00	-	0.83	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	-	0.00	0.00	-	0.21	0.00	0.00	0.00
Other Current Assets	0.93	1.86	2.28	2.29	5.74	5.11	5.11	0.03	0.07	0.02	0.09
Total Current Assets	8.89	3.30	6.88	6.88	25.80	32.71	32.71	2.93	0.07	0.03	0.54
Non-Current Assets
Property, Plant & Equipment (Net)	0.63	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.00
Long-Term Investments	0.40	0.00	0.00	-	0.00	0.00	-	0.00	32.01	70.77	69.03
Goodwill	1.79	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.00
Intangible Assets	0.93	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.32	0.35	0.43	0.43	0.02	0.02	0.02	0.01	0.00	0.00	0.00
Total Non-Current Assets	4.06	0.35	0.43	0.43	0.02	0.02	0.02	0.01	32.01	70.77	69.03
Total Assets	12.96	3.65	7.32	7.32	25.82	32.73	32.73	2.94	32.07	70.80	69.57
Current Liabilities
Accounts Payable	4.27	4.13	4.63	4.63	2.08	3.69	3.69	3.15	0.00	0.55	0.09
Short-Term Debt	0.32	1.57	9.16	9.16	7.70	0.52	0.52	0.25	0.00	0.00	0.00
Current Portion of Long-Term Debt	-	1.25	-	9.16	7.70	-	0.52	0.25	-	-	-
Accrued Liabilities	11.69	10.53	-	5.24	5.77	-	2.84	3.28	-	-	-
Other Current Liabilities	23.99	16.17	5.26	0.02	0.04	7.72	4.87	42.71	0.62	0.00	0.01
Total Current Liabilities	28.58	21.86	19.05	19.05	15.59	11.92	11.92	46.16	0.62	0.57	0.09
Non-Current Liabilities
Long-Term Debt	0.32	5.01	0.00	-	2.82	0.00	-	0.55	1.95	0.69	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.32	5.01	0.00	-	2.82	0.00	-	0.55	1.95	0.69	0.00
Total Liabilities	28.89	26.87	19.05	19.05	18.41	11.92	11.92	46.71	2.57	1.26	0.09
Stockholders' Equity
Common Stock	0.03	0.02	0.08	0.01	0.07	0.06	0.06	0.04	24.50	64.54	64.48
Retained Earnings	-306.90	-278.27	-253.15	-253.15	-223.00	-183.24	-183.24	-90.18	0.37	-0.04	-0.11
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Additional Paid-in Capital	290.93	255.04	241.33	241.41	230.34	203.99	203.99	46.37	4.63	5.04	5.10
Shares Outstanding	31.73	14.59	-	8.39	6.64	-	5.88	-	-	-	-
Total Stockholders' Equity	-15.94	-23.22	-11.73	-11.73	7.41	20.81	20.81	-43.77	29.50	69.54	69.47
Total Liabilities & Equity	12.96	3.65	7.32	7.32	25.82	32.73	32.73	2.94	32.07	70.80	69.57

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NRx Pharmaceuticals Balance Sheet

How much debt does NRx Pharmaceuticals have?

NRx Pharmaceuticals had total debt of $631.00K as of Dec 31, 2025, against $7.80M in cash and short-term investments. Total debt was $6.58M a year earlier.

What are NRx Pharmaceuticals's total assets?

NRx Pharmaceuticals reported total assets of $12.96M as of Dec 31, 2025, up 254.9% from $3.65M a year earlier. Total liabilities were $28.89M.

What is NRx Pharmaceuticals's shareholders' equity?

NRx Pharmaceuticals's shareholders' equity was negative at −$15.94M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition